Investigation Overview
May 25, 2016 (Shareholders Foundation) - An investigation on behalf of current long-term investors in shares of Hologic, Inc. (NASDAQ:HOLX) was announced over potential breaches of fiduciary duties by certain officers and directors at Hologic.
The investigation by a law firm concerns whether certain Hologic directors breached their fiduciary duties.
Hologic, Inc. reported that its Total Revenue rose from over $2.49 billion for the 12 months period that ended on Sept. 28, 2013 to over $2.7 billion for the 12 months period that ended on Sept. 26, 2015 and that its Net Loss of over $1.17 billion for the 12 months period that ended on Sept. 28, 2013 turned into a Net Income of $131.60 million for the 12 months period that ended on Sept. 26, 2015
On Apirl 27, 2016, Hologic, Inc. (NASDAQ:HOLX) reported its results for its second quarter of fiscal 2016 and issued its financial guidance for its fiscal 2016.
Shares of Hologic, Inc. (NASDAQ:HOLX) declined from $38.05 per share on April 27, 2016 to $33.02 per share on April 29, 2016.